According to ICMR, enrollment in the Phase 3 clinical trial of India’s first dengue vaccine is almost complete.
India is currently facing a significant challenge with dengue fever, as there is no approved antiviral treatment or licensed vaccine available in the country. Despite being among the top 30 countries with the highest incidence of dengue, efforts to control this mosquito-borne disease have largely depended on vector control and symptomatic treatment.
The absence of a licensed vaccine means that millions remain vulnerable every year, especially during the monsoon season when mosquito breeding peaks. Dengue, caused by the dengue virus transmitted through the Aedes aegypti mosquito, manifests in symptoms ranging from mild fever and joint pain to severe complications such as hemorrhagic fever and dengue shock syndrome, which can be fatal.
Currently, the management of dengue cases in India relies on early diagnosis and supportive care, including hydration and monitoring for warning signs. The healthcare system faces immense pressure during outbreaks, with hospitals experiencing high patient loads and resource constraints.
Recognizing the urgent need for preventive measures, the Indian Council of Medical Research (ICMR) and other research bodies have prioritized the development of an effective dengue vaccine. The introduction of such a vaccine would be a game-changer, potentially reducing the disease burden and associated healthcare costs significantly.
Meanwhile, public health initiatives continue to focus on controlling mosquito populations through fumigation, elimination of stagnant water, and raising awareness about protective measures such as using mosquito nets and repellents. Community participation remains crucial in these efforts to reduce dengue transmission.
Experts emphasize that while vaccine development progresses, comprehensive strategies including surveillance, prompt clinical management, and vector control are essential to mitigate the impact of dengue across India. Continued research, funding, and public cooperation will play vital roles in combating this persistent public health threat.
